Acute Ischemic Stroke and COVID-19: Experience From a Comprehensive Stroke Center in Midwest US

Parneet Grewal1, Pranusha Pinna1, Julianne P Hall1

  • 1Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, United States.

Frontiers in Neurology
|September 25, 2020
PubMed

Insights

COVID-19 increases the risk of acute ischemic stroke (AIS), particularly in African-American and Latino populations. This study found COVID-19 associated with worse stroke outcomes, suggesting coagulopathy and endothelial dysfunction as potential causes.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Cardiology

Background:

  • COVID-19 is linked to a higher risk of thromboembolic events, including ischemic stroke.
  • Understanding the impact of COVID-19 on acute ischemic stroke (AIS) is crucial, especially in diverse populations.

Purpose of the Study:

  • To analyze the characteristics and outcomes of patients with acute ischemic stroke (AIS) and COVID-19.
  • To compare AIS patients with and without COVID-19 to identify specific risks and outcomes.

Main Methods:

  • Retrospective analysis of AIS patients with COVID-19 admitted to a comprehensive stroke center.
  • Comparison with historical AIS cohorts without COVID-19 from 2019 and 2020.
  • Review of stroke characteristics, etiologies, treatment, and composite outcomes.

Main Results:

  • The cohort of AIS patients with COVID-19 was predominantly of Latino and African-American ethnicity.
  • A significant proportion of strokes were cortical and categorized as embolic stroke of unknown source (ESUS).
  • COVID-19 was associated with worse outcomes (mRS > 2) and a trend towards less alteplase administration.

Conclusions:

  • AIS in the context of COVID-19 is associated with poorer outcomes, particularly in minority populations.
  • High rates of large vessel disease with ESUS suggest coagulopathy and endothelial dysfunction as potential etiologies.
  • Further research is needed to elucidate the mechanisms and optimize management of stroke in COVID-19 patients.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
132
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.6K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
456